FDA approves generic Parkinson’s disease drug made by Actavis
MORRISTOWN, N.J. — The Food and Drug Administration has approved a treatment for Parkinson’s disease made by Actavis, the drug maker said Friday.
Actavis, which last month signed a deal with Watson Pharmaceuticals to be acquired for $5.6 billion, announced the approval and launch of ropinirole extended-release tablets in the 2-mg, 4-mg, 6-mg, 8-mg and 12-mg strengths.
The drug is a generic version of GlaxoSmithKline’s Requip XL, which had sales of about $59.4 million in 2011, according to IMS Health.
Dr. Reddy’s launches generic version of Plavix
HYDERABAD, India — Generic drug maker Dr. Reddy’s Labs has launched a generic version of a drug used to prevent clotting of the blood.
Dr. Reddy’s announced Friday the launch of clopidogrel tablets in the 75-mg and 300-mg strengths. The drug is a generic version of Plavix, made by Bristol-Myers Squibb and Sanofi. As one of the first companies to submit a completed regulatory application for the 300 mg strength of the drug, Dr. Reddy’s received 180 days of market exclusivity for it.
Plavix had sales of $6.74 billion during the 12-month period ended in March, according to IMS Health.
Mylan sponsors Drug Store News and Pharmacist Society to provide a new business networking platform for pharmacy schools and students
PITTSBURGH and NEW YORK — The Drug Store News Group, the Pharmacist Society and Mylan Inc., one of the world’s leading generics and specialty pharmaceutical companies, are pleased to announce an exclusive sponsorship to expand membership opportunities at PharmacistSociety.com — an online forum that supports and enhances professional networks for U.S.-based retail pharmacists, professional organizations and pharmacy companies. Through Mylan’s sponsorship of this program, pharmacy schools and students now will be invited to join the site and connect with established industry participants. The Pharmacist Society offers free, members-only access, encouraging collaboration, communication and knowledge sharing within a pharmacy-specific network.
Wayne Bennett, publisher of The Drug Store News Group, said: “Pharmacists continue to play an increasingly important role in the health care equation. They are at the front line of delivery in terms of providing access to medicine, continuity of care, patient monitoring, and disease management. Through the Pharmacist Society, and Mylan’s sponsorship, we’re excited to open this online community to future U.S. pharmacists and provide students and university programs a chance to engage with the industry’s ongoing conversation.”
Tony Mauro, president of Mylan North America and Mylan Pharmaceuticals, said, “At Mylan, we are committed to setting new standards in health care and providing high quality medicine to the world’s 7 billion people. We believe pharmacists play a vital role in this mission. The Pharmacist Society provides access to a valuable network of resources that enhance the ability of pharmacists to do their jobs, and we are proud to support this important professional tool.”
Since its launch in 2011, the Pharmacist Society has grown to include 45,000 registered pharmacists, and the extension of the site’s membership to include the student and alumni bases of the nation’s 130 pharmacy schools and colleges represents an opportunity to further expand the site’s networking impact.